logo

For the Inventor, By the Inventor

Bridgewater, NJ, United States of America

John J Tegeler

USPTO Granted Patents = 63

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 147(Granted Patents)

Forward Citations (Not Self Cited) = 137(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:

goldMedal43 out of 539 
 
Hoechst Roussel Pharmaceuticals
 patents
silverMedal12 out of 236 
 
Hoechst Marion Roussel
 patents
bronzeMedal4 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents
4. 1 out of 1 
 
Hoescht Roussel Pharmaceuticals Inc.
 patent
5. 1 out of 1 
 
Hoeschst-roussel Incorporated
 patent
6. 2 out of 832,843 
Other
 patents

Years Active: 1985-2002

Loading Chart...
Areas of Expertise:
Heteroarylpiperidines
Pyrrolidinealkylamines
Piperazine Alkylamines
Phthalimides
Dioxanes
Indoles
Alkylaminocarbonyl
Antipsychotics
Analgesics
Topical Anti-Inflammatory Agents
Propanediols
63 patents (USPTO):Explore Patents
1. 6500849 - 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino 1,3-propanediols and related compounds (2002-12-31),
2. 6420390 - Heteroarylpiperidines and their use as antipsychotics (2002-07-16),
3. 6251907 - 1-(aryloxyalkyl)-4-(heteroaryl) piperazines and related compounds useful as antipsychotics and analgesics (2001-06-26),
4. 6207680 - Heteroarylpiperidines and their use as antipsychotics and analgesics (2001-03-27),
5. 6043240 - 3-heteroaryl-1-pyrrolidinealkylamines and derivatives thereof and their (2000-03-28),
6. 5998417 - N-[(4-heteroaryl-1-piperazinyl) alkyl]phthalimides and related compounds (1999-12-07),
7. 5977147 - 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino- 1,3-propanediols and (1999-11-02),
8. 5977140 - N-[(4-Heteroaryl-1-Piperidinyl)Alkly] Phthalimides and related compounds (1999-11-02),
9. 5977113 - 4-heteroaryl-1-piperazine alkylamines and their therapeutic utility (1999-11-02),
10. 5965546 - 1-[(2-pyrimidinyloxy)alkyl]4-(heteroaryl)piperazines and related (1999-10-12),
11. 5919798 - 4-heteroaryl-1-piperidinealkanols and derivatives thereof and their (1999-07-06),
12. 5889004 - 4-heteroaryl-1-piperazinealkylthiols and derivatives thereof and their (1999-03-30),
13. 5874435 - 4-heteroaryl-1-piperazinealkanols and derivatives thereof and their (1999-02-23),
14. 5854243 - 3-heteroaryl-1-pyrrolidinealkylthiols and derivatives thereof and their (1998-12-29),
15. 5840727 - (4-heteroaryl)-1-�(2,3-dihydro-1H-isoindol-2-yl) alkyl! piperazines and (1998-11-24),

Title: Innovations and Contributions of John J Tegeler

Introduction

John J Tegeler is a notable inventor based in Bridgewater, NJ, recognized for his impressive portfolio of 63 patents. His work primarily focuses on pharmaceutical compounds and their applications in treating various medical conditions, showcasing his dedication to innovation in the healthcare sector.

Latest Patents

Among his latest patents, Tegeler has introduced groundbreaking compounds such as 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols. These novel compounds and their related processes emphasize methods for reducing inflammation, inhibiting cell proliferation, alleviating memory dysfunction, and preventing bacterial and fungal growth. Additionally, he has developed heteroarylpiperidines, which are significant in treating psychoses and serve as effective analgesics, thus contributing valuable advancements in psychotropic therapies.

Career Highlights

Throughout his impactful career, John Tegeler has worked with major pharmaceutical companies, including Hoechst Roussel Pharmaceuticals and Hoechst Marion Roussel. His contributions have led to significant advancements in the field of pharmaceuticals, focusing on the synthesis and application of various chemical compounds to improve patient care and treatment efficacy.

Collaborations

Collaboration has been a vital aspect of Tegeler's professional journey. He has worked alongside esteemed colleagues such as Joseph T Strupczewski and Edward J Glamkowski, fostering an environment of shared knowledge and innovation. Together, they have made strides in developing effective therapeutic solutions that continue to be relevant in modern medicine.

Conclusion

In summary, John J Tegeler's contributions to the field of pharmacology through his extensive patent portfolio highlight his role as a key innovator. His dedication to improving healthcare through chemistry continues to influence current and future medical practices, while his collaborations reflect a commitment to collective advancement in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…